Biosenta (XCNQ:ZRO) Short Interest

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Biosenta Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

XCNQ:ZRO vs PG, CL, KVUE: Short Interest Comparison

For the Household & Personal Products subindustry, Biosenta's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Biosenta Short Interest vs Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Biosenta's Short Interest distribution charts can be found below:

* The bar in red indicates where Biosenta's Short Interest falls into.


Biosenta Business Description

Address 18 Wynford Drive, Suite 704, Toronto, ON, CAN, M3C 3S2
Biosenta Inc develops antimicrobial products that offer environmentally friendly solutions to a global market. The company is dedicated to the advancement of technology that combats microbial growth in various materials. Its proprietary nanoparticle represents a breakthrough in antimicrobial technology, providing durable protection against a wide spectrum of bacteria, molds, and fungi. The company is engaged in developing sales for True product lines and the development for commercial applications of its technology to produce an antimicrobial Tri-Filler product.